Flucloxacillin 2000 mg powder for solution for injection/infusion
Authorisation PA1862/003/004 · Ibigen Srl
- Licence holder
- Ibigen Srl (all products →)
- Active substance
- Flucloxacillin
- Dosage form
- Powder for solution for injection/infusion
- Routes of administration
- Intramuscular use, Intravenous use
- ATC codes
- J01CF, J01CF05
- First authorised
- 26/08/2016
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Hybrid application (Article 10(3) of Directive No 2001/83/EC)
Flucloxacillin: supply and approvals
32 authorised products on the HPRA list contain Flucloxacillin. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 18 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 18 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 18 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 10 years (since 26 August 2016). The HPRA list marks it as marketed in Ireland.
Other medicines with Flucloxacillin in Ireland
17 other products on the HPRA list contain Flucloxacillin, from 6 licence holders; 14 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Floxapen 1000 mg powder for solution for injection or infusion | Teva B.V. | National authorisation (PA) | Marketed |
| Floxapen 2000 mg powder for solution for injection or infusion | Teva B.V. | National authorisation (PA) | Marketed |
| Floxapen 250mg Powder for solution for Injection or Infusion | Teva B.V. | National authorisation (PA) | Marketed |
| Floxapen 500 mg Powder for Solution for Injection or Infusion | Teva B.V. | National authorisation (PA) | Marketed |
| Flucillin – Flucloxacillin Capsules 250 mg | Pinewood Laboratories Ltd | National authorisation (PA) | Marketed |
| Flucillin – Flucloxacillin capsules 500 mg | Pinewood Laboratories Ltd | National authorisation (PA) | Marketed |
| Flucloxacillin 1000 mg Powder for solution for injection/infusion | Ibigen Srl | National authorisation (PA) | Marketed |
| Flucloxacillin 125mg/5ml Oral Solution | Athlone Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| Flucloxacillin 250 mg Capsules | Athlone Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| Flucloxacillin 250 mg Powder for solution for injection/infusion | Ibigen Srl | National authorisation (PA) | Marketed |
| Flucloxacillin 250mg/5ml Oral Solution | Athlone Pharmaceuticals Limited | National authorisation (PA) | Marketed |
| Flucloxacillin 500 mg Powder for solution for injection/infusion | Ibigen Srl | National authorisation (PA) | Marketed |
Other substances in ATC group J01CF
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 2 other active substances share the group J01CF with this product:
FLUCLOXACILLIN SODIUM (3) · Flucloxacillin sodium monohydrate (3)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Ibigen Srl holds 6 products on the HPRA list, with 3 different active substances; 6 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.